Le Lézard
Classified in: Science and technology
Subjects: Contract/Agreement, Funding

Blue Heron Capital Invests in Redi Health to Modernize Patient Support Services and Expand Healthcare Access


Blue Heron Capital, an early-stage growth equity firm, is excited to announce its investment in Redi Health, a digital health innovator poised to transform patient support services. This strategic investment is core to Blue Heron's philosophy of identifying and supporting companies that not only show potential for growth but also address pressing needs within healthcare and technology sectors experiencing meaningful transformation.

The $14M Series B funding round was led by Blue Heron Capital with participation from inside investors Refinery Ventures, Mutual Capital Partners, Rev1 Ventures, and M25. Redi Health plans to use this investment to foster innovation, develop and launch new products, further expand its patient network, and accelerate growth?effectively improving patient health outcomes by connecting Pharma, Providers, and Patients on a single platform.

Redi Health addresses the critical gap in patient support for those navigating complex, high-cost medications. Traditional Patient Support Programs (PSPs), hindered by outdated structures and inaccessibility, have contributed to a non-adherence rate of approximately 70%, leading to estimated losses of over $600 billion annually for the pharmaceutical industry. Redi Health's innovative platform offers a holistic approach to patient care, providing medication reminders, symptom management, educational resources, and real-time information exchange.

Luke Buchanan, Co-Founder and CEO of Redi Health, stated, "With Blue Heron Capital's backing, we are at a pivotal moment where we can significantly enhance patient care and outcomes. This investment validates the hard work of our team and the unwavering support of our investors, as we aim to make comprehensive care accessible to millions more across the country."

The investment in Redi Health underscores Blue Heron Capital's commitment to fostering innovation that transcends boundaries and empowers patients. Appointing Blue Heron OA Collaborative member Jim Clair to the Board of Directors reinforces this commitment, signaling confidence in Redi Health's vision and leadership team.

"Our investment in Redi is not merely a financial decision; it's an embodiment of our trust in the co-founders' vision, talent, and grit," added Gordon Crenshaw, Partner at Blue Heron Capital. "We are eager to support these entrepreneurs as they empower patients to improve their health journey."

About Redi Health

Redi Health empowers patients with chronic conditions to understand, manage, and track their total health through digital support. Their mobile and web platform, Redi Health, integrates health management technology with pharmaceutical manufacturer support, providing a seamless patient experience.

About Blue Heron Capital

Blue Heron Capital is an early-stage growth equity firm funding big ideas in healthcare and enterprise technology. Leveraging a powerful combination of financial capital and the human capital of its OA Collaborative, Blue Heron partners with companies to build businesses that make big impacts.

For additional information, please visit www.blueheroncap.com.


These press releases may also interest you

at 12:06
Telna, a trailblazer in global eSIM connectivity, today announced the divestiture of its KnowRoaming brand to eSimplified. This transfer positions eSimplified?an innovative entity supported by robust private equity and led by fintech and...

at 09:30
Aurionpro Solutions Limited (BSE: 532668) (NSE: AURIONPRO) announces the acquisition of Banking and Insurance focused PaaS startup, Arya.ai. With Arya.ai, Aurionpro will enhance its portfolio of enterprise fintech offerings to expedite adoption of AI...

at 07:47
Aurionpro Solutions Limited (BSE: 532668) (NSE: AURIONPRO) announces the acquisition of Banking and Insurance focused PaaS startup, Arya.ai. With Arya.ai, Aurionpro will enhance its portfolio of enterprise fintech offerings to expedite adoption of AI...

at 07:28
BioArctic AB (publ) today announced that BioArctic AB and Eisai Co., Ltd., have entered into a research evaluation agreement regarding BAN2802, a potential new treatment combining BioArctic's proprietary BrainTransportertm technology with an...

at 06:00
OKX, a leading Web3 technology company, today announced that it now supports deposits and withdrawals of ORDI and SATS tokens on the Merlin Chain. This integration expands the range of networks available to OKX users for managing these key Web3...

at 05:00
Shoplooks, an industry-leading influencer network, celebrates another milestone achievement after being recognized at the US Partnership Awards (USPA) 2024. Shoplooks won the Best Content Partnership Award for its influencer marketing campaign with...



News published on and distributed by: